Sign Up to like & get
recommendations!
1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0262068
Abstract: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used orally in conjunction with diet and exercise to control sugar levels in type 2 Diabetes Mellitus patients. This study aimed to extemporaneously prepare SiP solution…
read more here.
Keywords:
stability;
extemporaneously prepared;
sitagliptin phosphate;
solution ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Current Pharmaceutical Analysis"
DOI: 10.2174/1573412919666230417081123
Abstract: Sitagliptin phosphate monohydrate-dapagliflozin propanediol hydrate fixeddose combination (FDC) dual-layered tablet is used for type 2 diabetes treatment. Simultaneous quantitative analysis can shorten the analysis time of sitagliptin phosphate monohydrate-dapagliflozin propanediol monohydrate FDC dual-layered tablets and…
read more here.
Keywords:
monohydrate;
dapagliflozin propanediol;
monohydrate dapagliflozin;
analysis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13020228
Abstract: Cholesterol efflux is a major atheroprotective function of high-density lipoproteins (HDLs) which removes cholesterol from the foam cells of lipid-rich plaques in Type 2 diabetes. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin phosphate increases plasma glucagon-like…
read more here.
Keywords:
glp;
cholesterol;
sitagliptin phosphate;
cholesterol efflux ... See more keywords